Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$90.8K Sell
19,750
-982
-5% -$6.54K ﹤0.01% 2935
2026
Q1
$143K Sell
20,732
-36,850
-64% -$358K ﹤0.01% 2846
2025
Q4
$582K Buy
+57,582
New +$817K ﹤0.01% 2180

Other funds holding NVX

Marshall Wace's NVX Position: Q2 2026 in Review

Marshall Wace reduced its NOVONIX (NVX) stake by 4.7% in Q2 2026, selling an estimated $6.54K and leaving 19,750 shares worth $90.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2935.

Marshall Wace first reported a position in NVX in Q4 2025 and has held it in 3 quarters since. The position peaked at $582K in Q4 2025. 25 funds tracked by Wall St. Rank hold NVX as of Q2 2026.

  • Marshall Wace held 19,750 shares of NOVONIX worth $90.8K as of Q2 2026.
  • Marshall Wace sold 982 NOVONIX shares in Q2 2026, an estimated $6.54K.
  • NOVONIX made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2935 holding.
  • Marshall Wace first reported a position in NOVONIX in Q4 2025 and has held it in 3 quarters since.
  • Marshall Wace's NOVONIX position peaked at $582K in Q4 2025.
  • 25 funds tracked by Wall St. Rank held NOVONIX as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.